Home-Based Digital Rehabilitation Program Optimized With Transcutaneous Spinal Cord Stimulation for Upper Limb Functional Enhancement in Tetraplegia (HOPE): A Safety, Efficacy, and Feasibility Study
Key facts
- Who runs it
- Singapore General Hospital
- Where
- Singapore1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 9 people, planned
- Started
- Apr 2026
- Expected to end
- Dec 2027
- Type of study
- Interventional, 3 groups
- Treatments tested
- Home-based digital rehabilitation programme with tSCS
- Record updated
- 27 February 2026
Who can take part
- Age
- 21 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 25 criteriaShow less
Who can take part
- Participant
- Age 21 -75 years
- Non-progressive cervical SCI/spinal cord dysfunction (traumatic or non-traumatic)
- Duration of SCI/spinal cord dysfunction more than or equal to 12 months
- ASIA Impairment scale (AIS B, C, or D) with impaired upper limb function
- At least one hand capable of grasp and pinch, with or without assistive modification
- International Standards for Neurological Classification of Spinal Cord Injury-Upper Extremity Measurement Scale (ISNCSCI-UEMS) more than or equal to 20
- Able to maintain an upright sitting position for at least 30 minutes
- No contraindication for tSCS (e.g., no pacemakers or other implantable stimulators)
- Motivated and able to engage in a daily home-based rehabilitation program
- Availability of a dedicated care-giver to set up digital home-based therapy program; Caregiver
- Age 21 -75 years
- As identified by the patient as the caregiver
- Willing to participate in the study
Who cannot take part
- Prior exposure to tSCS treatment
- Significant or unstable medical co-morbidities including uncontrolled cardiopulmonary disease, severe cognitive impairment, severe dysautonomia, as determined by the investigator
- History of other neurologic conditions affecting upper limb function, such as stroke, multiple sclerosis, or traumatic brain injury
- Known history of peripheral neuropathy (diabetic polyneuropathy, entrapment neuropathy, etc)
- Ongoing treatment for cancer
- Skin conditions or active cancerous lesion that limit the application of tSCS electrodes
- Participant
- Pregnancy
- Known contraindication for tSCS (pacemakers or other implantable stimulators)
- Inability to provide informed consent; Caregiver:
- Inability to provide informed consent
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 21 and 75 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Individuals with chronic cervical spinal cord injury (SCI) and tetraplegia commonly experience persistent impairment in upper limb function, leading to reduced independence and quality of life. Transcutaneous spinal cord stimulation (tSCS) is a non-invasive neuromodulation technique that has demonstrated potential to improve upper limb strength and function when combined with rehabilitation. However, access to tSCS is limited in Singapore due to cost, regulatory barriers, and the need for frequent outpatient therapy.
Read full original descriptionShow less
This study evaluates the safety, efficacy, and feasibility of a home-based digital rehabilitation program incorporating tSCS delivered using a commercially available neuromuscular electrical stimulation (NMES) device. Using a prospective, open-label single-case experimental design with multiple baselines across participants, individuals with chronic, non-progressive cervical SCI will receive daily home-based tSCS combined with an mobile application-guided upper limb exercise program. Upper limb function, quality of life, feasibility, and safety outcomes will be assessed longitudinally over a 22-week study period.
The 3 groups in the trial
- Group 1 (intervention at end of Week 4)Other group
Intervention begins at the end of week 4 and continues for 18 weeks till week 22
Treatment: Home-based digital rehabilitation programme with tSCS
- Group 2 (intervention at end of Week 10)Other group
Intervention begins at the end of week 10 and continues for 12 weeks till week 22
Treatment: Home-based digital rehabilitation programme with tSCS
- Group 3(intervention at end of Week 16)Other group
Intervention begins at the end of week 16 and continues for 6 weeks till week 22
Treatment: Home-based digital rehabilitation programme with tSCS
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Fit questions
- Built from NCT07438353, who can take part
- Record updated
- 27 February 2026